Các bài viết có thể truy cập công khai - Paolo CalabroTìm hiểu thêm
Không có ở bất kỳ nơi nào: 6
Role of dual lipid-lowering therapy in coronary atherosclerosis regression: evidence from recent studies
F Gragnano, P Calabrò
Atherosclerosis 269, 219-228, 2018
Các cơ quan ủy nhiệm: Government of Italy
von Willebrand factor and venous thromboembolism: pathogenic link and therapeutic implications
P Calabrò, F Gragnano, E Golia, EL Grove
Seminars in thrombosis and hemostasis 44 (03), 249-260, 2018
Các cơ quan ủy nhiệm: Government of Italy
Von Willebrand factor and cardiovascular disease: from a biochemical marker to an attractive therapeutic target
F Gragnano, E Golia, F Natale, R Bianchi, I Pariggiano, M Crisci, V Diana, ...
Current Vascular Pharmacology 15 (5), 404-415, 2017
Các cơ quan ủy nhiệm: Government of Italy
Lipoprotein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
C Pederiva, ME Capra, G Biasucci, G Banderali, E Fabrizi, M Gazzotti, ...
Atherosclerosis 349, 233-239, 2022
Các cơ quan ủy nhiệm: Government of Italy
Von Willebrand factor as a novel player in valvular heart disease: from bench to valve replacement
F Gragnano, M Crisci, MC Bigazzi, R Bianchi, S Sperlongano, F Natale, ...
Angiology 69 (2), 103-112, 2018
Các cơ quan ủy nhiệm: Government of Italy
Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy
E Monda, G Frisso, M Rubino, M Caiazza, A Esposito, A Cirillo, A Fusco, ...
Future Cardiology 17 (4), 647-654, 2021
Các cơ quan ủy nhiệm: Government of Italy
Có tại một số nơi: 37
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target
E Golia, G Limongelli, F Natale, F Fimiani, V Maddaloni, I Pariggiano, ...
Current atherosclerosis reports 16, 1-7, 2014
Các cơ quan ủy nhiệm: Government of Italy
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a …
M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ...
The Lancet 392 (10150), 835-848, 2018
Các cơ quan ủy nhiệm: Natural Sciences and Engineering Research Council of Canada
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute for Health Research, UK
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
The Lancet 398 (10312), 1713-1725, 2021
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research, National Institute for Health …
The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy
F Gragnano, S Sperlongano, E Golia, F Natale, R Bianchi, M Crisci, ...
Mediators of inflammation 2017 (1), 5620314, 2017
Các cơ quan ủy nhiệm: Government of Italy
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international …
P Paolisso, L Bergamaschi, G Santulli, E Gallinoro, A Cesaro, F Gragnano, ...
Cardiovascular Diabetology 21 (1), 77, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ...
The Lancet 399 (10326), 719-728, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health, Netherlands Organisation for Scientific …
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
F Gragnano, D Cao, L Pirondini, A Franzone, HS Kim, M von Scheidt, ...
Journal of the American College of Cardiology 82 (2), 89-105, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2
R Rossini, G Tarantini, G Musumeci, G Masiero, E Barbato, P Calabro, ...
Cardiovascular Interventions 11 (5), 417-434, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
P Paolisso, L Bergamaschi, F Gragnano, E Gallinoro, A Cesaro, C Sardu, ...
Pharmacological research 187, 106597, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy
L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ...
Advances in therapy 34, 1200-1210, 2017
Các cơ quan ủy nhiệm: Government of Italy
Adipose tissue and vascular inflammation in coronary artery disease
E Golia, G Limongelli, F Natale, F Fimiani, V Maddaloni, PE Russo, ...
World journal of cardiology 6 (7), 539, 2014
Các cơ quan ủy nhiệm: Government of Italy
Hypertrophic cardiomyopathy in RASopathies: diagnosis, clinical characteristics, prognostic implications, and management
M Lioncino, E Monda, F Verrillo, E Moscarella, G Calcagni, F Drago, ...
Heart failure clinics 18 (1), 19, 2021
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ